ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
FRA:ACT - Deutsche Boerse Ag - DE000A2YNT30 - Common Stock - Currency: EUR
Taking everything into account, ACT scores 8 out of 10 in our fundamental rating. ACT was compared to 61 industry peers in the Chemicals industry. ACT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ACT is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, ACT could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
ACT had positive earnings in the past year.
ACT had a positive operating cash flow in the past year.
In the past 5 years ACT has always been profitable.
ACT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ACT's Return On Assets of 11.18% is amongst the best of the industry. ACT outperforms 96.83% of its industry peers.
The Return On Equity of ACT (26.31%) is better than 98.41% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.95%, ACT belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ACT is significantly above the industry average of 6.72%.
The 3 year average ROIC (12.06%) for ACT is below the current ROIC(14.95%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.18% | ||
| ROE | 26.31% | ||
| ROIC | 14.95% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
ACT's Profit Margin of 9.76% is amongst the best of the industry. ACT outperforms 82.54% of its industry peers.
ACT's Profit Margin has improved in the last couple of years.
ACT has a Operating Margin of 14.16%. This is amongst the best in the industry. ACT outperforms 84.13% of its industry peers.
ACT's Operating Margin has improved in the last couple of years.
ACT has a better Gross Margin (64.27%) than 96.83% of its industry peers.
In the last couple of years the Gross Margin of ACT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.16% | ||
| PM (TTM) | 9.76% | ||
| GM | 64.27% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ACT is creating value.
Compared to 1 year ago, ACT has less shares outstanding
ACT has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ACT has been reduced compared to a year ago.
2.2 Solvency
ACT has an Altman-Z score of 4.27. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.27, ACT belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
The Debt to FCF ratio of ACT is 0.85, which is an excellent value as it means it would take ACT, only 0.85 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.85, ACT belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that ACT is not too dependend on debt financing.
ACT has a better Debt to Equity ratio (0.21) than 76.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 0.85 | ||
| Altman-Z | 4.27 |
ROIC/WACC2.21
WACC6.77%
2.3 Liquidity
A Current Ratio of 2.48 indicates that ACT has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.48, ACT is doing good in the industry, outperforming 73.02% of the companies in the same industry.
A Quick Ratio of 1.52 indicates that ACT should not have too much problems paying its short term obligations.
ACT has a better Quick ratio (1.52) than 73.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.48 | ||
| Quick Ratio | 1.52 |
3. Growth
3.1 Past
ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.41%, which is quite impressive.
The Earnings Per Share has been growing by 24.60% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 2.51% in the past year.
ACT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.06% yearly.
EPS 1Y (TTM)56.41%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%37.07%
Revenue 1Y (TTM)2.51%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%-2.63%
3.2 Future
ACT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.89% yearly.
The Revenue is expected to grow by 8.08% on average over the next years. This is quite good.
EPS Next Y7.77%
EPS Next 2Y10.7%
EPS Next 3Y18.36%
EPS Next 5Y15.89%
Revenue Next Year4.75%
Revenue Next 2Y4.71%
Revenue Next 3Y5.58%
Revenue Next 5Y8.08%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 16.39, the valuation of ACT can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of ACT indicates a rather cheap valuation: ACT is cheaper than 82.54% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, ACT is valued a bit cheaper.
With a Price/Forward Earnings ratio of 15.90, ACT is valued correctly.
Based on the Price/Forward Earnings ratio, ACT is valued a bit cheaper than the industry average as 65.08% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ACT to the average of the S&P500 Index (22.10), we can say ACT is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.39 | ||
| Fwd PE | 15.9 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ACT is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
79.37% of the companies in the same industry are more expensive than ACT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.31 | ||
| EV/EBITDA | 8.39 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACT does not grow enough to justify the current Price/Earnings ratio.
ACT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ACT's earnings are expected to grow with 18.36% in the coming years.
PEG (NY)2.11
PEG (5Y)0.67
EPS Next 2Y10.7%
EPS Next 3Y18.36%
5. Dividend
5.1 Amount
ACT has a Yearly Dividend Yield of 2.11%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.89, ACT has a dividend in line with its industry peers.
ACT's Dividend Yield is comparable with the S&P500 average which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.11% |
5.2 History
The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
ACT pays out 22.58% of its income as dividend. This is a sustainable payout ratio.
ACT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.58%
EPS Next 2Y10.7%
EPS Next 3Y18.36%
FRA:ACT (3/7/2025, 7:00:00 PM)
87.2
+1.8 (+2.11%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners25.86%
Inst Owner ChangeN/A
Ins Owners46.03%
Ins Owner ChangeN/A
Market Cap887.70M
Analysts86
Price Target77.21 (-11.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.11% |
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP22.58%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.38%
PT rev (3m)4.07%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.4%
EPS NY rev (3m)2.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.18%
Revenue NY rev (3m)-6.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.39 | ||
| Fwd PE | 15.9 | ||
| P/S | 1.6 | ||
| P/FCF | 14.31 | ||
| P/OCF | 8.44 | ||
| P/B | 4.32 | ||
| P/tB | 4.4 | ||
| EV/EBITDA | 8.39 |
EPS(TTM)5.32
EY6.1%
EPS(NY)5.49
Fwd EY6.29%
FCF(TTM)6.09
FCFY6.99%
OCF(TTM)10.33
OCFY11.84%
SpS54.44
BVpS20.19
TBVpS19.83
PEG (NY)2.11
PEG (5Y)0.67
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.18% | ||
| ROE | 26.31% | ||
| ROCE | 20.74% | ||
| ROIC | 14.95% | ||
| ROICexc | 17.85% | ||
| ROICexgc | 18.06% | ||
| OM | 14.16% | ||
| PM (TTM) | 9.76% | ||
| GM | 64.27% | ||
| FCFM | 11.2% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexcg growth 3Y25.57%
ROICexcg growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 0.85 | ||
| Debt/EBITDA | 0.41 | ||
| Cap/Depr | 163.77% | ||
| Cap/Sales | 7.78% | ||
| Interest Coverage | 33.75 | ||
| Cash Conversion | 100.34% | ||
| Profit Quality | 114.74% | ||
| Current Ratio | 2.48 | ||
| Quick Ratio | 1.52 | ||
| Altman-Z | 4.27 |
F-Score7
WACC6.77%
ROIC/WACC2.21
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.41%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%37.07%
EPS Next Y7.77%
EPS Next 2Y10.7%
EPS Next 3Y18.36%
EPS Next 5Y15.89%
Revenue 1Y (TTM)2.51%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%-2.63%
Revenue Next Year4.75%
Revenue Next 2Y4.71%
Revenue Next 3Y5.58%
Revenue Next 5Y8.08%
EBIT growth 1Y36.94%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year43.09%
EBIT Next 3Y23.19%
EBIT Next 5Y21.62%
FCF growth 1Y19.06%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y44.69%
OCF growth 3Y34.7%
OCF growth 5Y19.23%